AAAAAA

   
Results: 1-25 | 26-50 | 51-53
Results: 26-50/53
EFFECT OF CYCLOSPORINE ON IMMUNOGENICITY OF A BACTERIAL ENZYME CARBOXYPEPTIDASE G2 IN ADEPT
Authors: SHARMA SK BAGSHAWE KD MELTON RG BEGENT RHJ
Citation: Sk. Sharma et al., EFFECT OF CYCLOSPORINE ON IMMUNOGENICITY OF A BACTERIAL ENZYME CARBOXYPEPTIDASE G2 IN ADEPT, Transplantation proceedings, 28(6), 1996, pp. 3154-3155
EXTENDED GLYCOPROTEIN STRUCTURE OF THE 7 DOMAINS IN HUMAN CARCINOEMBRYONIC ANTIGEN BY X-RAY AND NEUTRON SOLUTION SCATTERING AND AN AUTOMATED CURVE-FITTING PROCEDURE - IMPLICATIONS FOR CELLULAR ADHESION
Authors: BOEHM MK MAYANS MO THORNTON JD BEGENT RHJ KEEP PA PERKINS SJ
Citation: Mk. Boehm et al., EXTENDED GLYCOPROTEIN STRUCTURE OF THE 7 DOMAINS IN HUMAN CARCINOEMBRYONIC ANTIGEN BY X-RAY AND NEUTRON SOLUTION SCATTERING AND AN AUTOMATED CURVE-FITTING PROCEDURE - IMPLICATIONS FOR CELLULAR ADHESION, Journal of Molecular Biology, 259(4), 1996, pp. 718-736
SINGLE-CHAIN FV ANTIBODIES FOR TARGETING CANCER-THERAPY
Authors: BEGENT RHJ CHESTER KA
Citation: Rhj. Begent et Ka. Chester, SINGLE-CHAIN FV ANTIBODIES FOR TARGETING CANCER-THERAPY, Immunology, 89, 1996, pp. 113-113
ABLATION OF COLORECTAL XENOGRAFTS WITH COMBINED RADIOIMMUNOTHERAPY AND TUMOR BLOOD FLOW-MODIFYING AGENTS
Authors: PEDLEY RB BODEN JA BODEN R BOXER GM FLYNN AA KEEP PA BEGENT RHJ
Citation: Rb. Pedley et al., ABLATION OF COLORECTAL XENOGRAFTS WITH COMBINED RADIOIMMUNOTHERAPY AND TUMOR BLOOD FLOW-MODIFYING AGENTS, Cancer research, 56(14), 1996, pp. 3293-3300
PREPARATION, CHARACTERIZATION AND TUMOR TARGETING OF CROSS-LINKED DIVALENT AND TRIVALENT ANTITUMOR FAB' FRAGMENTS
Authors: CASEY JL KING DJ CHAPLIN LC HAINES AMR PEDLEY RB MOUNTAIN A YARRANTON GT BEGENT RHJ
Citation: Jl. Casey et al., PREPARATION, CHARACTERIZATION AND TUMOR TARGETING OF CROSS-LINKED DIVALENT AND TRIVALENT ANTITUMOR FAB' FRAGMENTS, British Journal of Cancer, 74(9), 1996, pp. 1397-1405
POLYETHYLENE-GLYCOL MODIFICATION OF A GALACTOSYLATED STREPTAVIDIN CLEARING AGENT - EFFECTS ON IMMUNOGENICITY AND CLEARANCE OF A BIOTINYLATED ANTITUMOR ANTIBODY
Authors: MARSHALL D PEDLEY RB BODEN JA BODEN R MELTON RG BEGENT RHJ
Citation: D. Marshall et al., POLYETHYLENE-GLYCOL MODIFICATION OF A GALACTOSYLATED STREPTAVIDIN CLEARING AGENT - EFFECTS ON IMMUNOGENICITY AND CLEARANCE OF A BIOTINYLATED ANTITUMOR ANTIBODY, British Journal of Cancer, 73(5), 1996, pp. 565-572
ENHANCED TUMOR SPECIFICITY OF AN ANTI-CARCINOEMBRIONIC ANTIGEN FAB' FRAGMENT BY POLY(ETHYLENE GLYCOL) (PEG) MODIFICATION
Authors: DELGADO C PEDLEY RB HERRAEZ A BODEN R BODEN JA KEEP PA CHESTER KA FISHER D BEGENT RHJ FRANCIS GE
Citation: C. Delgado et al., ENHANCED TUMOR SPECIFICITY OF AN ANTI-CARCINOEMBRIONIC ANTIGEN FAB' FRAGMENT BY POLY(ETHYLENE GLYCOL) (PEG) MODIFICATION, British Journal of Cancer, 73(2), 1996, pp. 175-182
PLACENTAL SITE TROPHOBLASTIC TUMORS AT CHARING
Authors: BOWER M RUSTIN GJS BEGENT RHJ BAGSHAWE KD NEWLANDS ES
Citation: M. Bower et al., PLACENTAL SITE TROPHOBLASTIC TUMORS AT CHARING, European journal of cancer, 31A, 1995, pp. 1169-1169
ANTIBODIES FROM PHAGE LIBRARIES - CLINICAL IMAGING TRIAL OF A FILAMENTOUS BACTERIOPHAGE-DERIVED SINGLE-CHAIN FV ANTI-CEA EXPRESSED IN ESCHERICHIA-COLI
Authors: BEGENT RHJ CHESTER KA CASEY J GREEN AJ NAPIER MP HOPESTONE L KEEP PA ROBSON L LANE DM JOHNSON CJ
Citation: Rhj. Begent et al., ANTIBODIES FROM PHAGE LIBRARIES - CLINICAL IMAGING TRIAL OF A FILAMENTOUS BACTERIOPHAGE-DERIVED SINGLE-CHAIN FV ANTI-CEA EXPRESSED IN ESCHERICHIA-COLI, European journal of cancer, 31A, 1995, pp. 16-16
SECONDARY TUMORS FOLLOWING ETOPOSIDE CONTAINING THERAPY FOR GERM-CELLCANCER
Authors: BOSHOFF C BEGENT RHJ OLIVER RTD RUSTIN GJ NEWLANDS ES ANDREWS R SKELTON M HOLDEN L ONG J
Citation: C. Boshoff et al., SECONDARY TUMORS FOLLOWING ETOPOSIDE CONTAINING THERAPY FOR GERM-CELLCANCER, Annals of oncology, 6(1), 1995, pp. 35-40
DISTINCT INFLUENCE OF PEGYLATION ON THE TUMOR-LOCALIZATION OF TRANSFERRIN AND A TUMOR-SPECIFIC FAB FRAGMENT (F9)
Authors: DELGADO C HERRAEZ A AGRAWAL AK PEDLEY RB FISHER D BEGENT RHJ FRANCIS GE
Citation: C. Delgado et al., DISTINCT INFLUENCE OF PEGYLATION ON THE TUMOR-LOCALIZATION OF TRANSFERRIN AND A TUMOR-SPECIFIC FAB FRAGMENT (F9), Journal of cellular biochemistry, 1995, pp. 171-171
PURIFICATION OF BACTERIALLY EXPRESSED SINGLE-CHAIN FV ANTIBODIES FOR CLINICAL-APPLICATIONS USING METAL CHELATE CHROMATOGRAPHY
Authors: CASEY JL KEEP PA CHESTER KA ROBSON L HAWKINS RE BEGENT RHJ
Citation: Jl. Casey et al., PURIFICATION OF BACTERIALLY EXPRESSED SINGLE-CHAIN FV ANTIBODIES FOR CLINICAL-APPLICATIONS USING METAL CHELATE CHROMATOGRAPHY, Journal of immunological methods, 179(1), 1995, pp. 105-116
A SINGLE-CHAIN FV DERIVED FROM A FILAMENTOUS PHAGE LIBRARY HAS DISTINCT TUMOR TARGETING ADVANTAGES OVER ONE DERIVED FROM A HYBRIDOMA
Authors: VERHAAR MJ CHESTER KA KEEP PA ROBSON L PEDLEY RB BODEN JA HAWKINS RE BEGENT RHJ
Citation: Mj. Verhaar et al., A SINGLE-CHAIN FV DERIVED FROM A FILAMENTOUS PHAGE LIBRARY HAS DISTINCT TUMOR TARGETING ADVANTAGES OVER ONE DERIVED FROM A HYBRIDOMA, International journal of cancer, 61(4), 1995, pp. 497-501
GALACTOSYLATED STREPTAVIDIN FOR IMPROVED CLEARANCE OF BIOTINYLATED INTACT AND F(AB')(2) FRAGMENTS OF AN ANTITUMOR ANTIBODY
Authors: MARSHALL D PEDLEY RB MELTON RG BODEN JA BODEN R BEGENT RHJ
Citation: D. Marshall et al., GALACTOSYLATED STREPTAVIDIN FOR IMPROVED CLEARANCE OF BIOTINYLATED INTACT AND F(AB')(2) FRAGMENTS OF AN ANTITUMOR ANTIBODY, British Journal of Cancer, 71(1), 1995, pp. 18-24
PRODUCTION OF A HIGH-AFFINITY ANTI-CEA SCFV FOR COLORECTAL TUMOR TARGETING
Authors: CHESTER KA BEGENT RHJ ROBSON L KEEP PA PEDLEY RB BODEN J BOXER G GREEN A WINTER G COCHET O HAWKINS RE
Citation: Ka. Chester et al., PRODUCTION OF A HIGH-AFFINITY ANTI-CEA SCFV FOR COLORECTAL TUMOR TARGETING, Journal of cellular biochemistry, 1994, pp. 198-198
PHAGE LIBRARIES FOR GENERATION OF CLINICALLY USEFUL ANTIBODIES
Authors: CHESTER KA BEGENT RHJ ROBSON L KEEP P PEDLEY RB BODEN JA BOXER G GREEN A WINTER G COCHET O HAWKINS RE
Citation: Ka. Chester et al., PHAGE LIBRARIES FOR GENERATION OF CLINICALLY USEFUL ANTIBODIES, Lancet, 343(8895), 1994, pp. 455-456
ENHANCEMENT OF RADIOIMMUNOTHERAPY BY DRUGS MODIFYING TUMOR BLOOD-FLOWIN A COLONIC XENOGRAFT MODEL
Authors: PEDLEY RB BEGENT RHJ BODEN JA BOXER GM BODEN R KEEP PA
Citation: Rb. Pedley et al., ENHANCEMENT OF RADIOIMMUNOTHERAPY BY DRUGS MODIFYING TUMOR BLOOD-FLOWIN A COLONIC XENOGRAFT MODEL, International journal of cancer, 57(6), 1994, pp. 830-835
PRODUCTION AND TUMOR-BINDING CHARACTERIZATION OF A CHIMERIC ANTI-CEA FAB EXPRESSED IN ESCHERICHIA-COLI
Authors: CHESTER KA ROBSON L KEEP PA PEDLEY RB BODEN JA BOXER GM HAWKINS RE BEGENT RHJ
Citation: Ka. Chester et al., PRODUCTION AND TUMOR-BINDING CHARACTERIZATION OF A CHIMERIC ANTI-CEA FAB EXPRESSED IN ESCHERICHIA-COLI, International journal of cancer, 57(1), 1994, pp. 67-72
IMPROVED TUMOR TARGETING WITH CHEMICALLY CROSS-LINKED RECOMBINANT ANTIBODY FRAGMENTS
Authors: KING DJ TURNER A FARNSWORTH APH ADAIR JR OWENS RJ PEDLEY RB BALDOCK D PROUDFOOT KA LAWSON ADG BEELEY NRA MILLAR K MILLICAN TA BOYCE BA ANTONIW P MOUNTAIN A BEGENT RHJ SHOCHAT D YARRANTON GT
Citation: Dj. King et al., IMPROVED TUMOR TARGETING WITH CHEMICALLY CROSS-LINKED RECOMBINANT ANTIBODY FRAGMENTS, Cancer research, 54(23), 1994, pp. 6176-6185
THE LONG-TERM OUTCOME OF PATIENTS WHO RELAPSE AFTER CHEMOTHERAPY FOR NONSEMINOMATOUS GERM-CELL TUMORS
Authors: LEDERMANN JA HOLDEN L NEWLANDS ES BEGENT RHJ RUSTIN GJS BAGSHAWE KD BRAMPTON M
Citation: Ja. Ledermann et al., THE LONG-TERM OUTCOME OF PATIENTS WHO RELAPSE AFTER CHEMOTHERAPY FOR NONSEMINOMATOUS GERM-CELL TUMORS, British Journal of Urology, 74(2), 1994, pp. 225-230
THE POTENTIAL FOR ENHANCED TUMOR-LOCALIZATION BY POLY(ETHYLENE GLYCOL) MODIFICATION OF ANTI-CEA ANTIBODY
Authors: PEDLEY RB BODEN JA BODEN R BEGENT RHJ TURNER A HAINES AMR KING DJ
Citation: Rb. Pedley et al., THE POTENTIAL FOR ENHANCED TUMOR-LOCALIZATION BY POLY(ETHYLENE GLYCOL) MODIFICATION OF ANTI-CEA ANTIBODY, British Journal of Cancer, 70(6), 1994, pp. 1126-1130
RADIOIMMUNOTHERAPY OF METASTATIC COLORECTAL TUMORS WITH IODINE-131-LABELED ANTIBODY TO CARCINOEMBRYONIC ANTIGEN - PHASE I II STUDY WITH COMPARATIVE BIODISTRIBUTION OF INTACT AND F(AB')(2) ANTIBODIES/
Authors: LANE DM EAGLE KF BEGENT RHJ HOPESTONE LD GREEN AJ CASEY JL KEEP PA KELLY AMB LEDERMANN JA GLASER MG HILSON AJW
Citation: Dm. Lane et al., RADIOIMMUNOTHERAPY OF METASTATIC COLORECTAL TUMORS WITH IODINE-131-LABELED ANTIBODY TO CARCINOEMBRYONIC ANTIGEN - PHASE I II STUDY WITH COMPARATIVE BIODISTRIBUTION OF INTACT AND F(AB')(2) ANTIBODIES/, British Journal of Cancer, 70(3), 1994, pp. 521-525
CLEARANCE OF CIRCULATING RADIO-ANTIBODIES USING STREPTAVIDIN OR 2ND ANTIBODIES IN A XENOGRAFT MODEL
Authors: MARSHALL D PEDLEY RB BODEN JA BODEN R BEGENT RHJ
Citation: D. Marshall et al., CLEARANCE OF CIRCULATING RADIO-ANTIBODIES USING STREPTAVIDIN OR 2ND ANTIBODIES IN A XENOGRAFT MODEL, British Journal of Cancer, 69(3), 1994, pp. 502-507
LOCALIZATION OF MONOCLONAL-ANTIBODIES REACTING WITH DIFFERENT EPITOPES ON CARCINOEMBRYONIC ANTIGEN (CEA) - IMPLICATIONS FOR TARGETED THERAPY
Authors: BOXER GM ABASSI AM PEDLEY RB BEGENT RHJ
Citation: Gm. Boxer et al., LOCALIZATION OF MONOCLONAL-ANTIBODIES REACTING WITH DIFFERENT EPITOPES ON CARCINOEMBRYONIC ANTIGEN (CEA) - IMPLICATIONS FOR TARGETED THERAPY, British Journal of Cancer, 69(2), 1994, pp. 307-314
CD44 IS ASSOCIATED WITH PROLIFERATION IN NORMAL AND NEOPLASTIC HUMAN COLORECTAL EPITHELIAL-CELLS
Authors: ABBASI AM CHESTER KA TALBOT IC MACPHERSON AS BOXER G FORBES A MALCOLM ADB BEGENT RHJ
Citation: Am. Abbasi et al., CD44 IS ASSOCIATED WITH PROLIFERATION IN NORMAL AND NEOPLASTIC HUMAN COLORECTAL EPITHELIAL-CELLS, European journal of cancer, 29A(14), 1993, pp. 1995-2002
Risultati: 1-25 | 26-50 | 51-53